论文部分内容阅读
目的分析社区卫生服务中心2型糖尿病(T2DM)患者口服降糖药物情况。方法选取在社区卫生服务中心口服降糖药物治疗的T2DM患者234例作为研究对象,对患者的基本资料,使用口服降糖药物类型、规格、剂量,患者的血糖、糖化血红蛋白(Hb A1c),及并发症发生情况进行分析。结果社区卫生服务中心接收的患者以>60岁老年人为主,男女比例相当;使用口服降糖药物比例由高到低依次为α-葡萄糖苷酶抑制、磺酰脲类、双胍类、噻唑烷二酮类。Hb A1c达标患者并发症发生率明显低于Hb A1c未达标患者。结论社区卫生服务中心针对T2DM患者选择降糖药物时应视患者具体情况进行分析调查。
Objective To analyze the oral antidiabetic drugs in patients with type 2 diabetes mellitus (T2DM) in community health centers. Methods A total of 234 T2DM patients treated with oral hypoglycemic agents in community health centers were selected as study objects. The basic data of patients were analyzed using oral hypoglycemic agents, their dosage, blood sugar, Hb A1c, The incidence of complications were analyzed. Results The community-based health service centers received more than 60-year-olds and had a fairly high ratio of male to female. The proportion of oral hypoglycemic agents in descending order was α-glucosidase inhibition, sulfonylureas, biguanides, Ketones. Hb A1c compliance rate of patients with complications was significantly lower than the Hb A1c patients who did not meet. Conclusion Community health service center for patients with T2DM select hypoglycemic agents should be analyzed according to the specific circumstances of patients.